Evidence map›Paper›PMID 22948034›Full record

ArticleAging2012

A filtering strategy identifies FOXQ1 as a potential effector of lamin A dysfunction.

Jose Candelario, Leng-Ying Chen, Paul Marjoram, Sita Reddy, Lucio Comai

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jose CandelarioDepartment of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA 90033, USA.
Leng-Ying Chen
Paul Marjoram
Sita Reddy
Lucio Comai
University of Southern California · US

Funding

Role of the Werner syndrome protein complex in the metabolism of chromosome endsR01AG034156 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI COMAI, LUCIO · 2010 to 2014
$1.8M
Biochem. Characterization of Hutchinson-Gilford Progeria SyndromeF31GM076861 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CANDELARIO, JOSE · 2006 to 2009
$164k
EXTRAMURAL RESEARCH FACILITIES CONTRUCTION PROJECTC06CA062528 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KEDES, LAURENCE H · 1993 to 1994
–
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR010600 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KEDES, LAURENCE H · 1994 to 1994
–
RESEARCH FACILITIES IMPROVEMENT PROGRAM AND REMODELINGC06RR014514 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KEDES, LAURENCE H · 1999 to 1999
–
NCI NIH HHS C06 CA062528NCI NIH HHS C06 CA62528NCRR NIH HHS C06 RR014514NCRR NIH HHS C06 RR014514-01NCRR NIH HHS C06 RR10600-01NIA NIH HHS R01 AG034156NIGMS NIH HHS F31 GM076861NIGMS NIH HHS F31GM076861
6 · The paper itself

Abstract

Small increases in the expression of wild-type prelamin A are sufficient to recapitulate the reduced cell proliferation and altered nuclear membrane morphology observed in cells expressing progerin, the mutant lamin A associated with progeria. We hypothesized that the manifestation of these phenotypes in cells expressing elevated levels of wild-type prelamin A or progerin is caused by the same molecular effectors, which play a central role in the onset of the progeroid phenotype. To experimentally test this hypothesis, we compared the transcriptomes of isogenic diploid fibroblasts expressing progerin or elevated levels of wild-type prelamin A with that of wild-type fibroblasts. We subsequently used the reversion towards normal of two phenotypes, reduced cell growth and dismorphic nuclei, by treatment with farnesyltransferase inhibitor (FTI) or overexpression of ZMPSTE24, as a filtering strategy to identify genes linked to the onset of these two phenotypes. Through this analysis we identified the gene encoding for the transcription factor FOXQ1, as a gene whose expression is induced in both cells expressing progerin and elevated levels of wild-type prelamin A, and subsequently reduced in both cell types upon conditions that ameliorate the phenotypes. We overexpressed FOXQ1 in normal fibroblasts and demonstrated that increased levels of this factor lead to the development of both features that were used in the filtering strategy. These findings suggest a potential link between this transcription factor and cell dysfunction induced by altered prelamin A metabolism.

Indexed as

Cell LineFarnesyltranstransferaseFibroblastsForkhead Transcription FactorsGene ExpressionGene Expression ProfilingHumansLamin Type AMembrane ProteinsMetalloendopeptidasesNuclear EnvelopeNuclear ProteinsProgeriaProtein PrecursorsReverse Transcriptase Polymerase Chain ReactionFarnesyltranstransferaseForkhead Transcription FactorsLamin Type AMembrane ProteinsMetalloendopeptidasesNuclear Proteinsprelamin AProtein PrecursorsZMPSTE24 protein, human

Identifiers

PMID22948034
PMCPMC3461344
OpenAlexW2114707670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.